A skeletal muscle-sympathetic nerve-intestine network underlies muscle inflammation and atrophy induced by immobilization

This study reveals that limb immobilization triggers a skeletal muscle-sympathetic nerve-intestine network where sympathetic activation of intestinal macrophages via $\beta$2-adrenergic receptors drives gut inflammation and the release of CXCL10, ultimately causing skeletal muscle inflammation and atrophy.

The Gist

Imagine your body is a bustling city. The muscles are the heavy-duty construction crews that keep the city moving. The intestines are the massive recycling and waste management plant. And the nervous system? That's the city's police and fire department, constantly patrolling and sending out signals to keep everything running smoothly.

Usually, if you stop working (like when you're in a cast because of a broken leg), the construction crews just slow down because they aren't being asked to do any work. But this new research discovered something surprising: When you stop moving, your body doesn't just "rest"; it actually starts a chain reaction of chaos that travels from your muscles, to your nerves, all the way to your gut, and then comes back to destroy your muscles.

Here is the story of how that happens, broken down into simple steps:

1. The Initial Shock: The "Catabolism" Phase

When you first get immobilized (say, for 3 days), your muscles start to shrink. This is the "expected" part. It's like a construction crew that hasn't been paid or given materials for a few days; they start breaking down their own tools to survive. The body breaks down muscle protein to get energy. This happens quickly, but it's a relatively simple process.

2. The Twist: The "Inflammation" Phase

But if you stay in the cast for longer (about 10 days), something new and dangerous kicks in. The muscles don't just shrink; they get inflamed. It's like the construction crew suddenly starts a riot. They are flooded with immune cells (specifically, a type of white blood cell called a macrophage) that are screaming "Help!" and attacking the muscle tissue.

The researchers found a specific "siren" causing this riot: a chemical signal called CXCL10. It's like a loudspeaker blaring an alarm that tells the immune system to invade the muscle.

3. The Secret Culprit: The Gut

Here is where it gets weird. The researchers asked: Why is the muscle screaming for help? They discovered the answer wasn't in the muscle at all. It was in the intestines.

When you stop moving, your gut bacteria (the tiny microbes living in your belly) go crazy. The "good" bacteria die off, and the "bad" bacteria take over. This causes the intestinal wall to get leaky and inflamed. Think of it like the recycling plant catching fire and leaking toxic smoke into the city.

4. The Messenger: The Sympathetic Nervous System

How does the muscle know the gut is on fire? The body has a "police radio" called the sympathetic nervous system (the part that handles stress, like "fight or flight").

When you are immobilized, this nervous system gets overactive and sends a specific signal to the gut. It's like the police chief shouting into the radio, "Everyone, get ready!" This signal hits a specific receptor on the gut's immune cells (the beta-2 adrenergic receptor). This causes the gut immune cells to panic, the gut bacteria to change, and the gut to become inflamed.

5. The Loop Closes

Once the gut is inflamed, it releases toxic chemicals (like bacterial fragments) into the bloodstream. These toxins travel to the muscles, triggering the "CXCL10" siren. The muscles then get inflamed and start wasting away rapidly.

The Cycle:
Immobilization ➔ Overactive Nerves ➔ Gut Bacteria Chaos ➔ Inflamed Gut ➔ Toxins in Blood ➔ Muscle Inflammation ➔ Muscle Wasting.

The Good News: We Found the "Off" Switches

The researchers didn't just find the problem; they found two ways to stop it:

1. Silence the Siren: They gave the mice antibodies that blocked the CXCL10 signal. It was like putting a mute button on the loudspeaker. The muscles stopped getting inflamed and didn't waste away as much.
2. Fix the Gut: They gave the mice a specific fatty acid metabolite called HYA (a substance made by good gut bacteria). This acted like a fire extinguisher for the gut. It calmed the gut inflammation and fixed the bacterial balance. Even though the mice were still in a cast, their muscles stayed strong because the "toxic smoke" from the gut was gone.

Why This Matters

This discovery changes how we think about muscle loss. It's not just about "not using" the muscle. It's a team effort gone wrong between your muscles, your nerves, and your gut.

This is huge for people who are bedridden, elderly, or recovering from surgery. Instead of just trying to exercise (which might be impossible), doctors might be able to:

• Give patients a specific probiotic or fatty acid supplement (like HYA) to calm the gut.
• Use drugs to block the specific "siren" (CXCL10) in the muscles.

In short: To save the muscles, you might need to heal the gut. It's a reminder that our body parts are all connected, like a complex city where a fire in the recycling plant can bring down the construction crews miles away.

Technical Summary

1. Problem Statement

Muscle atrophy induced by limb immobilization (e.g., due to casting, bed rest, or nerve injury) is a common clinical complication leading to loss of physical function and metabolic health. While previous research established that short-term immobilization triggers rapid muscle mass loss via a Piezo1/KLF15/IL-6 axis driving protein catabolism, the mechanisms underlying prolonged immobilization-induced atrophy remained unclear. Specifically, the transition from early catabolic processes to later inflammatory states, and the potential role of extra-muscular organs (such as the gut) and the nervous system in this process, had not been elucidated.

2. Methodology

The study employed a multi-disciplinary approach combining mouse models, human clinical samples, and advanced omics technologies:

• Animal Models: Mice underwent bilateral hindlimb immobilization via cast-fixation or sciatic nerve denervation for periods ranging from 1 to 14 days.
• Intervention Strategies:
  • Pharmacological: Administration of neutralizing antibodies against CXCL10, antibiotics (to sterilize the gut), clodronate liposomes (to deplete macrophages), $\alpha$-methyl-p-tyrosine ($\alpha$-MT, to inhibit catecholamine synthesis), propranolol ($\beta_2$-adrenergic antagonist), and clenbuterol ($\beta_2$-agonist).
  • Dietary: Supplementation with linoleic acid (LA) and its metabolites (HYD and HYA).
  • Genetic: Generation of macrophage-specific Adrb2 knockout mice (M$\phi$-Adrb2KO) using LysM-Cre and Adrb2-floxed strains.
  • Neural Manipulation: Chemical sympathectomy (6-OHDA) and optogenetic/chemogenetic activation of intestinal sympathetic nerves (Cartpt-Cre mice).
• Omics and Analytical Techniques:
  • RNA-seq and scRNA-seq: Bulk RNA sequencing of muscle and colon tissue; single-cell RNA sequencing of the colon to identify cell-type-specific responses.
  • Microbiome Analysis: 16S rRNA gene sequencing of fecal samples.
  • Metabolomics: Mass spectrometry to quantify fatty acid metabolites in feces/cecum.
  • Physiological Assays: Measurement of norepinephrine (NE) turnover, plasma LPS levels, cytokine concentrations (ELISA), and flow cytometry for immune cell profiling.
• Human Validation: Analysis of skeletal muscle biopsies from patients with limb fractures (casted) and public gene expression datasets (GEO).

3. Key Contributions & Results

A. Temporal Transition from Catabolism to Inflammation

• Early Phase (Days 1–3): Immobilization initially drives muscle loss via protein catabolism (upregulation of Atrogin-1, MuRF1, and Klf15), consistent with previous findings.
• Late Phase (Days 7–10): A distinct shift occurs where inflammation becomes the dominant driver. There is a massive accumulation of macrophages (F4/80$^+$) in the muscle, a shift toward pro-inflammatory (CD11c$^+$CD206$^-$) subsets, and a surge in CXCL10 expression.
• CXCL10 as a Mediator: Neutralizing CXCL10 antibodies prevented macrophage accumulation, inflammation, and muscle atrophy in prolonged immobilization but had no effect on the early catabolic phase.

B. The Muscle-Gut Axis

• Intestinal Pathology: Prolonged immobilization caused intestinal shortening, crypt depth reduction, and a decrease in the barrier protein claudin-1, leading to increased plasma LPS (leaky gut).
• Microbiome Dysbiosis: Immobilization altered the gut microbiota, specifically increasing the Lachnospiraceae group and decreasing Lactobacillus.
• Causality:
  • Fecal Microbiota Transplantation (FMT) from non-immobilized mice to immobilized mice attenuated muscle inflammation and atrophy.
  • Antibiotic treatment (gut sterilization) prevented muscle atrophy.
  • Macrophage depletion in the colon (clodronate liposomes) similarly prevented muscle inflammation.
• Mechanism: LPS from the gut likely triggers CXCL10 upregulation in muscle, as LPS treatment of C2C12 myotubes induced Cxcl10 expression.

C. The Sympathetic Nervous System Link

• Neural Activation: Immobilization increased norepinephrine (NE) turnover specifically in the lower intestine (distal small intestine and colon), indicating heightened sympathetic activity.
• $\beta_2$-Adrenergic Signaling: Immobilization upregulated the $\beta_2$-adrenergic receptor (Adrb2) gene in the colon.
  • Chemical sympathectomy (6-OHDA) or $\beta_2$-blockade (propranolol) prevented intestinal inflammation, dysbiosis, and muscle atrophy.
  • Conversely, activating intestinal sympathetic nerves induced inflammation and muscle wasting.
• Cellular Target: scRNA-seq revealed that Adrb2 is highly expressed in intestinal macrophages. Crucially, immobilization increased the population of pro-inflammatory macrophages in the colon.
• Macrophage-Specific Knockout: In M$\phi$-Adrb2KO mice, immobilization failed to induce pro-inflammatory macrophage expansion in the colon, intestinal inflammation, or muscle atrophy. This confirms that Adrb2 signaling in intestinal macrophages is the critical node linking sympathetic activation to muscle pathology.

D. Therapeutic Intervention: 10-Hydroxy-cis-12-octadecenoic Acid (HYA)

• Immobilization reduced levels of the gut microbial metabolite HYA (derived from linoleic acid).
• Oral administration of HYA (but not LA or HYD) restored intestinal barrier function, reduced macrophage infiltration in the gut, prevented muscle inflammation, and attenuated atrophy.
• HYA acted independently of correcting the microbiome composition, suggesting a direct anti-inflammatory effect on the host.

4. Significance

This study uncovers a previously unrecognized skeletal muscle–sympathetic nerve–intestine network that drives immobilization-induced muscle atrophy.

• Mechanistic Insight: It resolves the "missing link" between limb immobilization and systemic muscle wasting, demonstrating that the gut acts as a sensor and amplifier of the stress response via sympathetic nerves and macrophages.
• Clinical Implications:
  • CXCL10 Inhibition: Suggests that anti-CXCL10 therapies could be effective for preventing inflammation-driven atrophy in immobilized patients.
  • HYA Supplementation: Identifies HYA as a promising, safe, and immediately translatable therapeutic candidate (currently in clinical trials) to prevent muscle loss by targeting intestinal inflammation.
  • Sympathetic Modulation: Highlights the potential of targeting the sympathetic nervous system or $\beta_2$-adrenergic signaling in the gut to mitigate muscle wasting in conditions requiring immobilization.

In conclusion, the paper redefines muscle atrophy not just as a local muscle response to disuse, but as a systemic condition mediated by a neuro-immune-gut axis, offering novel targets for therapeutic intervention.